Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Research programme: RNA therapeutics - PendreaBio

Next Previous
X
Search
Drug Profile

Research programme: RNA therapeutics - PendreaBio

Alternative Names: Anti-influenza siRNA NanoJackets; Cellular messaging influenza therapy - PendreaBio; KN 20; miRNA-NanoJackets; mRNA-NanoJackets; NJ-siRNA; RNAi therapy - PendreaBio; siRNA programme - PendreaBio; siRNA-NanoJackets - PendreaBio

Latest Information Update: 12 Oct 2023

Price :

$50 *

Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Keystone Nano
  • Developer PendreaBio
  • Class Anti-infectives; Antineoplastics; RNA
  • Mechanism of Action RNA interference
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No
  • Available For Licensing Yes - Cancer; Infections

Highest Development Phases

  • No development reported Cancer; Influenza virus infections

Most Recent Events

  • 28 Oct 2019 No recent reports of development identified for research development in Influenza-virus-infections in USA (Parenteral)
  • 28 Aug 2019 No recent reports of development identified for research development in Cancer(Treatment-resistant) in USA (Parenteral)
  • 27 Oct 2016 Research programme: RNA therapeutics - Keystone Nano is available for licensing as of 27 Oct 2016. http://www.keystonenano.com/partnering/areas_of_interest

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top